About FDA

Interactive Review

FY 2009 MDUFA Performance Report Table of Contents

FDA is applying the interactive review process to provide for and encourage informal communication between FDA and sponsors, and to facilitate timely completion of device reviews based on accurate and complete information. FDA issued a final guidance on the interactive review process in December 2007, and issued a revised edition in February 2008. The current edition of this guidance is available at: Interactive Review for Medical Device Submissions:
510(k)s, Original PMAs, PMA Supplements, Original BLAs, and BLA Supplements

Next page: Meetings

Page Last Updated: 09/09/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English